Newsroom

LONDON--(BUSINESS WIRE)--  ISIN Code. XS3063717386 Our Ref. MT0976 ISSUE NAME. City Of Goteborg Issue of SEK 1,534,000,000.00 Floating Rate Green Notes due May 2030 Series No GB44 Tranche 1 MTN INTEREST PERIOD. 05/05/2026 TO 03/08/2026 VALUE DATE. 03/08/2026 INTEREST RATE. 2.84 PCT NUM OF DAYS. 90 DAY BASIS. Actual/360 (A004) CURRENCY CODE. SEK TOTAL INTEREST AMT. SEK 10,891,400 POOL FACTOR. N/A...

ATLANTA--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: EARNEST Partners, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2992015979 Our Ref. MS4554 ISSUE NAME. CANADIAN IMPERIAL BANK OF COMMERCE Issue of EUR 600,000,000.00 Floating Rate Callable Senior Notes due Feb 2028 series 333 Tranche 1 MTN INTEREST PERIOD. 05/05/2026 TO 04/08/2026 VALUE DATE. 04/08/2026 INTEREST RATE. 2.819 PCT NUM OF DAYS. 91 DAY BASIS. Actual/360 (A004) CURRENCY CODE. EUR TOTAL INTEREST AMT. EUR 4,275,483.33 POOL FACTOR. N/A...

NEWPORT NEWS, Va.--(BUSINESS WIRE)--  On April 30, 2026, the Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) board of directors declared a dividend of $0.89 per share. The timetable for payment of the dividend is as follows: Ex-dividend date: May 15, 2026 Record date: May 15, 2026 Currency election deadline for Depositary Interest holders: June 11, 2026 Payment date: July 8, 2026 The completion of cross-border movements of shares between the U.K. and the U.S. is contingent upon the receiving...

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2758113190 Our Ref. MQ5772 ISSUE NAME. City of Stockholm Issue of SEK 600,000,000.00 Floating Rate Notes due May 2029 Series EMTN100 Tranche 1 MTN INTEREST PERIOD. 05/05/2026 TO 03/08/2026 VALUE DATE. 03/08/2026 INTEREST RATE. 2.84 PCT NUM OF DAYS. 90 DAY BASIS. Actual/360 (A004) CURRENCY CODE. SEK TOTAL INTEREST AMT. SEK 4,260,000 POOL FACTOR. N/A...

IRVINE, California, y ÁMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., empresa líder en oncología de precisión aplicada al cáncer de mama, ha anunciado hoy que presentará nuevos datos en el Congreso Anual de Cáncer de Mama de la Sociedad Europea de Oncología Médica (ESMO) 2026, que se celebrará del 6 al 8 de mayo en Berlín (Alemania). La empresa presentará dos comunicaciones en formato póster con datos del estudio prospectivo FLEX y de un análisis posterior independiente del ensayo de referencia MIN...

IRVINE, Californie et AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., un chef de file dans le domaine de l’oncologie de précision pour le cancer du sein, a annoncé aujourd’hui qu’elle présenterait de nouvelles données lors du Congrès annuel 2026 de la Société européenne d’oncologie médicale (Society for Medical Oncology, ESMO) consacré au cancer du sein, qui se tiendra du 6 au 8 mai à Berlin, en Allemagne. La société présentera deux affiches qui exposeront les résultats de l’étude prospective FLEX...

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., een leider in precisie-oncologie voor borstkanker, heeft vandaag aangekondigd dat het nieuwe gegevens zal presenteren op het jaarlijkse congres over borstkanker van de European Society for Medical Oncology (ESMO) in 2026, dat plaatsvindt van 6 t/m 8 mei in Berlijn, Duitsland. Het bedrijf zal twee posters presenteren met gegevens uit de prospectieve FLEX-studie en een onafhankelijke post-hoc-analyse van de baanbrekende MINDACT-studie,...

IRVINE, California e AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., leader nell'ambito dell'oncologia di precisione nel tumore del seno, ha annunciato oggi che presenterà nuovi dati in occasione del congresso annuale 2026 sul carcinoma mammario della European Society for Medical Oncology (ESMO), che si terrà dal 6 all'8 maggio a Berlino, in Germania. L'azienda presenterà due poster contenenti dati dallo studio prospettico FLEX e un'analisi post-hoc indipendente dello studio di riferimento MINDACT...

IRVINE, Kalifornien & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., ein führendes Unternehmen im Bereich der Präzisionsonkologie für Brustkrebs, gab heute bekannt, dass es auf dem Jahreskongress 2026 der European Society for Medical Oncology (ESMO) zum Thema Brustkrebs, der vom 6. bis 8. Mai in Berlin stattfindet, neue Daten vorstellen wird. Das Unternehmen wird zwei Poster präsentieren, die Daten aus der prospektiven FLEX-Studie und einer unabhängigen Post-hoc-Analyse der wegweisenden MINDACT-St...